Streamly
Categories & TopicsEvents & BrandsExperts
LoginSign Up
Categories & TopicsEvents & BrandsExperts
LoginSign Up
Carbon MitigationResiliencyEnergyResourcesBiodiversitySocial Sustainability Tools & FrameworksStrategy
Private CapitalBankingFintechWealth & Investment ManagementInsurance
Content StrategyData & AnalyticsSocial MediaLeadership & CultureMarketing Strategy
Growth StrategyLeadership & CultureTools & MethodologyCybersecurityTelecommunications
Leadership & CultureTools & MethodologyConsumer InsightsStrategy
RenewablesHydrogenBiofuelsEnergy & Battery StorageDecarbonisationInfrastructure & Development
Digital HealthChronic DiseaseAged Care & DisabilityHospital ManagementFunding, Policy & WorkforceLegal & Ethical IssuesBiotech & PharmaHealth Infrastructure
RestaurantsIndustryMenuCulinaryRetailWorkforceOperationsConsumers
Leadership & CultureStrategyDiversity, Equity & InclusionInspiration
Future of WorkLearning & Development Employee ExperienceHR TechLeadership & CultureTalent Acquisition
RailHaulage & Freight DecarbonisationInfrastructure
SustainabilityFinanceMarketingInnovation & TechnologyData & InsightsEnergyHealthcareFoodserviceLeadershipHRTransport & InfrastructureMeetings & EventsBuildings & Real Estate

Navigating the pathway to success in biotech

Navigating the pathway to success in biotech

0:00
0%
0:00
|
0:00
https://cdn.streamly.video/From_Lab_to_Market_Stories_of_Biotech_3_51a16b27a3.png
PREVIEW
BiotechPharma/BiotechResearch & development
Rebecca McQualterRebecca McQualterChief Operating Officer/Acting CEO at Chimeric Therapeutics Ltd

Dr. Rebecca McQualter is the Chief Operating Officer and Acting CEO of Chimeric Therapeutics Ltd, based in Melbourne, Australia.

With over two decades of experience in the biotech industry, Dr. McQualter has been at the forefront of pioneering cell therapy innovations, leading the development of first-in-class CAR-T therapies targeting various cancers, including gastric, pancreatic, and glioblastoma.

Known for her strategic leadership and commitment to advancing cutting-edge technology, she plays a critical role in shaping the future of biotech and improving patient outcomes globally.

Making psychedelic therapy accessible and affordable
Making psychedelic therapy accessible and affordableDr. Prash Puspanathan
Driving innovation in biotech
Driving innovation in biotechDr. Nina Webster
Why AI is the future of clinical trials
Why AI is the future of clinical trialsSaurabh Jain
How to invest with purpose and profit in the biotech industry
How to invest with purpose and profit in the biotech industry Emerald Scofield
The key to a successful capital raise & non-dilutive funding
The key to a successful capital raise & non-dilutive fundingJames Graham
Navigating the pathway to biotech success
Navigating the pathway to biotech successMegan Baldwin
Show more content
Description

Join us for an insightful interview with Dr. Rebecca McQualter, the Chief Operating Officer and Acting CEO of Chimeric Therapeutics Ltd.

With a wealth of experience in the biotech sector, Dr. McQualter shares her journey from starting in the industry at 21 to leading a pioneering company in cell therapy.

Dr. McQualter also addresses the daily challenges of running a biotech company, the importance of staying at the cutting edge of technology, and her dedication to improving patient outcomes.

This interview offers valuable insights for anyone interested in biotech, healthcare, or entrepreneurship.

Table Of Contents
Overview of Chimeric Therapeutics
Key Milestones and Challenges
Technology and Innovation
Staying Innovative and Future Outlook
0
Your cart